People: Clovis Oncology Inc (CLVS.OQ)
22 Apr 2019
Dr. Lindsey Rolfe, BSc, MB ChB, MRCP, FFPM., is Executive Vice President - Clinical and Pre-Clinical Development and Pharmacovigilance and Chief Medical Officer of the Company. Dr. Rolfe joined Clovis in April 2010 and served as Senior Vice President of Clinical Development until her promotion. Dr. Rolfe has 19 years of drug development experience and previously served in senior oncology development roles at Celgene Corporation, Pharmion Corporation (acquired in 2008), Cambridge Antibody Technology, UCB Inc. and Celltech Group plc. Dr. Rolfe qualified in medicine at the University of Edinburgh. She undertook post graduate medical training in London, UK and obtained her post-graduate internal medicine qualification as a Member of the Royal College of Physicians (MRCP). She has specialist accreditation in Pharmaceutical Medicine from the UK General Medical Council and is a Fellow of the Faculty of Pharmaceutical Medicine.
|Total Annual Compensation, USD||707,063|
|Restricted Stock Award, USD||683,100|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,039,520|
|Fiscal Year Total, USD||2,429,680|